Methyl 3-bromo-6-chloropicolinate

Catalog No. :
ACRCUM762
CAS No. :
1214328-96-7
Molecular Formula :
C7H5BrClNO2
Molecular Weight :
250.48

IUPAC Name:methyl 3-bromo-6-chloropicolinate

Methyl 3-bromo-6-chloropicolinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$69.00Login to see priceIn stockIn stock
10g95%$129.00Login to see priceIn stockIn stock
25g95%$316.00Login to see priceIn stockIn stock
100g95%$1226.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-bromo-6-chloropicolinate
IUPAC Namemethyl 3-bromo-6-chloropicolinate
MDL No.MFCD11976777
Molecular FormulaC7H5BrClNO2
Molecular Weight250.48
SMILESO=C(OC)C1=NC(Cl)=CC=C1Br
InChI KeyAPCPBNNLVCVDPL-UHFFFAOYSA-N
SynonymMethyl 3-bromo-6-chloropicolinate | 1214328-96-7 | methyl 3-bromo-6-chloropyridine-2-carboxylate | MFCD11976777 | 2-Pyridinecarboxylic acid, 3-bromo-6-chloro-, methyl ester | Methyl3-bromo-6-chloropicolinate | SCHEMBL2134852 | DTXSID00673233 | APCPBNNLVCVDPL-UHFFFAOYSA-N
CAS No.1214328-96-7
PubChem CID46311200

Synthetic Route by SureRoute

1. ACRCUM762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACIEFQ450 route compound structure diagram
    ACIEFQ450929000-66-8 In Stock
  4. Then
  5. ACRCUM762 route product structure diagram
    ACRCUM7621214328-96-7 In Stock
Inquiry

2. ACRCUM762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACIEFQ450 route compound structure diagram
    ACIEFQ450929000-66-8 In Stock
  4. Plus
  5. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  6. Then
  7. ACRCUM762 route product structure diagram
    ACRCUM7621214328-96-7 In Stock
Inquiry

Comments (0)